A resolution supporting the goals and ideals of "Deep Vein Thrombosis and Pulmonary Embolism Awareness Month".
Impact
The implications of SR116 extend beyond a mere acknowledgment; it emphasizes the need for increased public awareness concerning DVT and PE, particularly among high-risk groups such as cancer patients and pregnant women. The resolution outlines that effective awareness campaigns can potentially decrease the occurrence of such preventable fatalities, which represent considerable medical costs to the healthcare system, estimated at $10 billion annually. The Senate's support for this awareness initiative is seen as a vital step toward fostering a more health-conscious society.
Summary
Senate Resolution 116 (SR116) seeks to support the establishment of March as 'Deep Vein Thrombosis and Pulmonary Embolism Awareness Month'. This resolution highlights the seriousness of deep vein thrombosis (DVT) and its potentially life-threatening complication, pulmonary embolism (PE). As significant medical conditions that are often preventable, DVT and PE collectively affect approximately 900,000 individuals each year in the United States, leading to an estimated 60,000 to 100,000 deaths annually. This resolution serves to recognize the urgency of raising awareness about the dangers of these conditions.
Contention
While SR116 is a resolution that aims to unify efforts to increase awareness and education about DVT and PE, potential points of contention could arise regarding the allocation of resources for awareness initiatives. Some stakeholders may question if sufficient funding and support will accompany the resolution's goals to ensure it translates into tangible health outcomes, such as improved public education and access to preventive measures. Critics may also express concerns over prioritizing this cause among various health issues that require attention, ultimately influencing how effectively DVT and PE can be addressed at a broader healthcare policy level.